Detalhe da pesquisa
1.
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
Eur J Haematol
; 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38661269
2.
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice.
Acta Oncol
; 63: 267-272, 2024 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38709114
3.
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
Br J Haematol
; 201(1): 64-74, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36513500
4.
Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.
Oncologist
; 28(1): 59-71, 2023 01 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35881028
5.
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events.
Cancer Immunol Immunother
; 72(10): 3337-3347, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37486396
6.
Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysis.
Cancer
; 128(13): 2474-2482, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35417924
7.
Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma.
Br J Haematol
; 203(2): e78-e81, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37519227
8.
Late complications and survival of soft tissue sarcoma patients after adjuvant chemotherapy - a single tertiary centre experience.
Acta Oncol
; 62(9): 1152-1156, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37571925
9.
Link between disease status at 24 months and mortality in follicular lymphoma.
Br J Haematol
; 199(3): 458-462, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36028946
10.
[Treatment and prevention of iphosphamide-induced encephalopathy]. / lfosfamidin aiheuttama enkefalopatia.
Duodecim
; 132(4): 314-7, 2016.
Artigo
Finlandês
| MEDLINE | ID: mdl-27017785
11.
Development of renal cell carcinoma (RCC) diagnostics and impact on prognosis.
BJU Int
; 113(2): 228-35, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23890347
12.
Gut microbiome-derived bacterial extracellular vesicles in patients with solid tumours.
J Adv Res
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38458256
13.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37481365
14.
FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma.
Cancer Med
; 12(1): 407-411, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35661431
15.
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data.
JCO Clin Cancer Inform
; 7: e2300067, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37756639
16.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37530662
17.
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial.
Eur Urol
; 82(3): 283-292, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35210132
18.
Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months.
Leuk Lymphoma
; 62(7): 1639-1647, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33546574
19.
Changes in symptoms of renal cell carcinoma over four decades.
BJU Int
; 106(5): 649-53, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20151959
20.
Prognostic factors and long-term survival in renal cell cancer patients.
Scand J Urol Nephrol
; 43(6): 454-60, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19968581